Noninvasive Internal Jugular Venous Oximetry

NCT06004466 | Unknown

• 1 other identifier: 202203103DIND
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

In this study, we are developing a novel plethysmographic monitoring device which incorporates several key techniques: inclusion of structural information (ultrasound image), coupling with the estimation of local tissue optical parameters, consideration of the tissue scattering absorption coefficient of each subject, to finally calculate the noninvasive continuous internal jugular venous saturation.

Conditions

Neoplasms

Outcome Measures

Primary Outcomes (1)

• Internal jugular venous saturation

  To validate the estimation of noninvasive internal jugular venous saturation and the real value by obtaing the internal jugular venous blood during central venous catheter placement

  20 min

Eligibility Criteria

• Age: 20 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Adult cancer patients without organ dysfunction undergong planned central venous catheter placement for cancer surgery or totally implantable venous access device placement for future chemotherapy. During the central venous line placement, 3 ml blood sample from the internal jugular vein is obtained for internal validation of internal jugular venous saturation for our device.

You may qualify if:

• Patients undergoing major cancer surgery that requires central venous catheter placement
• Cancer patients undergoing totally implantable venous access device placement

You may not qualify if:

• Susepct infectious symptoms and signs (eg. white blood cell count count \>10000 ; fever \>38.3℃)
• impaired liver functions (aspartate aminotransferase\> 100 U/L); impaired renal function (estimated glomerular filtration rate \<60 mL/min/1.73 m2)
• heart failure, with New York Heart Associatation class 2 or more

Sponsors & Collaborators

• National Taiwan University Hospital: lead

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

• Chun-Yu Wu

  National Taiwan University Hospital

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Chun-Yu Wu

CONTACT

886976653376; b001089018@tmu.edu.tw

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 17, 2023
• First Posted: August 22, 2023
• Study Start: September 1, 2023
• Primary Completion: September 1, 2024
• Study Completion: September 1, 2024
• Last Updated: August 22, 2023

Record last verified: 2023-08

Locations

TW (1)